主动脉瓣狭窄多模态影像学最新进展
本文综述主动脉瓣狭窄及生物瓣退变的多模态影像学最新进展,涵盖超声心动图和CT评估狭窄严重程度与疾病进展、心脏MRI评估心肌健康与纤维化,以及18F-NaF PET/CT评估瓣膜疾病活动度和进展的机制性见解,探讨这些技术如何辅助患者管理并可能加速新型治疗开发。
要点
- 超声心动图和CT有助于改善主动脉瓣狭窄严重程度评估与疾病进展监测。
- 心脏MRI可提供心肌健康与纤维化形成的信息。
- 18F-NaF PET/CT可评估瓣膜疾病活动度和进展,提供机制性见解。
核心结论
- 多模态影像学技术可辅助主动脉瓣狭窄患者管理,并可能加速新型治疗开发。
研究设计与样本
- 本文为综述,检索范围未在原文中报告。
主要发现
- 超声心动图和CT的现代进展有助于改善主动脉瓣狭窄严重程度评估和疾病进展监测。
- 心脏MRI可提供心肌健康和纤维化形成的信息。
- 近期一系列研究显示18F-NaF PET/CT可评估瓣膜疾病活动度和进展,提供可指导潜在新型治疗方法的机制性见解。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aortic stenosis is a common condition associated with major morbidity, mortality, and health-care costs. Nevertheless, we currently lack any effective medical therapies that can treat or prevent disease development or progression. Modern advances in echocardiography and CT have helped improve the assessment of aortic stenosis severity and monitoring of disease progression, whereas cardiac MRI informs on myocardial health and the development of fibrosis. In a series of recent studies, 18F-NaF PET/CT has been shown to assess valvular disease activity and progression, providing mechanistic insights that can inform potential novel therapeutic approaches. This review will examine the latest advances in the imaging of aortic stenosis and bioprosthetic valve degeneration and explore how these techniques can assist patient management and potentially accelerate novel therapeutic developments.
引用
- Tzolos E, Kwiecinski J, Berman D, et al. Latest Advances in Multimodality Imaging of Aortic Stenosis. J Nucl Med. 2021. PMID: 34887339. doi:10.2967/jnumed.121.262304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。